PATENT CLAIM ANALYSIS

Application Number: 15885333
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-01
Patent Classification: ["514", "232800"]

Abstract:
Disclosed herein are compounds, pharmaceutical compositions, and related methods for the treatment of viral infection, including RNA viral infection in subjects. The compounds, pharmaceutical compositions, and methods can modulate the innate immune antiviral response in vertebrate cells, including activating the RIG-I pathway.

Claim (Index 34):
A method of modulating the innate immune response in a eukaryotic cell, comprising administering to the cell a compound of  claim 30 , or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 86.0
- Lexical Diversity: 1.51515
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13765583', '14348516', '15419784', '13640732', '14391638']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8020821229844639
- 35 USC 102 Novelty (BERT): 0.5404153320362799
- Combined Prediction Score: 0.7759154438896456
- Mean Citation Score: 353.882134
- Max Citation Score: 386.89203
- Similarity Product: 286.72836358686266

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test